On Monday, Cabaletta Bio Inc (NASDAQ: CABA) was 7.82% up from the session before settling in for the closing price of $3.71. A 52-week range for CABA has been $3.47 – $26.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -35.79%. With a float of $41.14 million, this company’s outstanding shares have now reached $47.82 million.
In an organization with 103 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 62.34%, operating margin of -2496.86%, and the pretax margin is -2243.97%.
Cabaletta Bio Inc (CABA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cabaletta Bio Inc stocks. The insider ownership of Cabaletta Bio Inc is 15.78%, while institutional ownership is 94.77%. The most recent insider transaction that took place on Jan 19 ’24, was worth 215,439. In this transaction an insider of this company sold 11,000 shares at a rate of $19.59, taking the stock ownership to the 20,000 shares. Before that another transaction happened on Dec 19 ’23, when Company’s See Remarks sold 11,000 for $21.89, making the entire transaction worth $240,789. This insider now owns 20,000 shares in total.
Cabaletta Bio Inc (CABA) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.37 earnings per share (EPS) during the time that was better than consensus figure (set at -0.4) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -35.79% per share during the next fiscal year.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
You can see what Cabaletta Bio Inc (CABA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 11.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -2.41 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.03 million. That was inferior than the volume of 1.09 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 26.48%. Additionally, its Average True Range was 0.37.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 5.27%, which indicates a significant decrease from 34.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.33% in the past 14 days, which was lower than the 110.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.44, while its 200-day Moving Average is $11.37. However, in the short run, Cabaletta Bio Inc’s stock first resistance to watch stands at $4.17. Second resistance stands at $4.33. The third major resistance level sits at $4.58. If the price goes on to break the first support level at $3.75, it is likely to go to the next support level at $3.50. The third support level lies at $3.33 if the price breaches the second support level.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
There are 48,849K outstanding shares of the company, which has a market capitalization of 204.20 million. As of now, sales total 0 K while income totals -67,680 K. Its latest quarter income was 0 K while its last quarter net income were -27,600 K.
